Press Releases Integrum AB

Equities

INTEG B

SE0009807266

Delayed Nasdaq Stockholm Other stock markets 03:22:19 2024-05-08 EDT			5-day change	1st Jan Change
51.8 ^SEK	+1.17%		-10.38%	+13.47%

05-02	Integrum Expands Its Product Offering to the United Kingdom Market	CI
03-26	Integrum Enters a Commercial agreement with AMI Technologies to introduce the OPRATM Implant System in Israel	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Integrum launches short video documentary to showcase the company's efforts to treat combat amputees in Ukraine	05-03	AQ
Integrum expands its product offering to the United Kingdom market	05-02	AQ
Integrum: CBPR operations suspended	04-26	AQ
Integrum: Anchoring its position as niche leader	04-11	AQ
Integrum expands its product offering into the Israeli market	03-26	AQ
Health economic study shows positive outcome using Integrum's OPRA[TM] Implant System over socket prostheses in transfemoral amputees	03-19	AQ
Integrum Q3 - In line and no estimate changes	03-01	AQ
A new record revenue quarter with 61% growth	02-29	AQ
Integrum AB, Invitation to the Third Quarter 2023, 24 Results Presentation	02-26	AQ
Integrum AB: Invitation to the Third Quarter 2023/24 Results Presentation	02-23	AQ
Integrum has sold and delivered OPRA[TM] Implant Systems to a value of SEK 3.5 million to Center of Excellence in Ukraine	01-31	AQ
Integrum establishes Center of Excellence in Ukraine	12-20	AQ
Integrum's MDR certification is completed for the OPRA[TM] Implant System	12-15	AQ
Integrum Q2 - Alive and kicking	12-05	AQ
Record sales and profitability	12-04	AQ
Integrum AB changes Certified Adviser to Carnegie Investment Bank AB (publ)	11-30	AQ
Integrum AB: Invitation to the Second Quarter 2023/24 Results Presentation	11-28	AQ
Integrum plans to submit a PMA application to the FDA for the use of OPRA in transhumeral amputations based on existing clinical data	11-13	AQ
Correction missing MAR reference: Integrum publishes preliminary revenue, result and and cash flow figures for Q2, 2023	11-10	AQ
Clinical study of Integrum's OPRA™ Implant System on below-knee amputations will include up to 30 patients and is fully funded by the Department of Defense	11-10	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Integrum AB

Equities

INTEG B

SE0009807266

Press Releases

Filters